Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James G. McCabe"'
Publikováno v:
American Journal of Veterinary Research. 76:272-279
OBJECTIVE To evaluate effectiveness of a commercially available toxoid manufactured from western diamondback (WD) rattlesnake (Crotalus atrox) venom against envenomation of mice with WD, northern Pacific (NP) rattlesnake (Crotalus oreganus oreganus),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b91bf17dba3b98c02fd20381a95722
https://doi.org/10.2460/ajvr.76.3.272
https://doi.org/10.2460/ajvr.76.3.272
Publikováno v:
Comparative medicine. 64(6)
Median lethal dose (LD50) testing in mice is the ‘gold standard’ for evaluating the lethality of snake venoms and the effectiveness of interventions. As part of a study to determine the murine LD50 of the venom of 3 species of rattlesnake, temper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5a2fdaf62a88abfb4f73515d8ec8c4e
https://pubmed.ncbi.nlm.nih.gov/25527024
https://pubmed.ncbi.nlm.nih.gov/25527024
Autor:
Timothy J, Corbin, James G, McCabe
Publikováno v:
Contemporary topics in laboratory animal science. 41(2)
The purpose of this study was to examine the response of rats of different genetic backgrounds to various superovulatory hormonal treatments. Immature Sprague Dawley (SD), FBNF1, and F344 female rats (30 to 35 days of age) were used for this study as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3db54670800e4077f5562890b29ebe61
https://pubmed.ncbi.nlm.nih.gov/11958598
https://pubmed.ncbi.nlm.nih.gov/11958598
Autor:
Lisa D. Taylor, Kathryn Wymore, Condie E. Carmack, Chiung-Chi Kuo, Susan L. O'Donnell, Tasha Bengoechea, Roshanak Mashayekh, Dianne M. Fishwild, Donna Munoz-O'Regan, Elizabeth S. G. Lapachet, James G. McCabe, Dennis Huszar, Robert M. Kay, Fiona A. Harding, Mary Trounstine, Kay M. Higgins, Nils Lonberg, Stephen R. Schramm
Publikováno v:
Nature. 368(6474)
Human sequence monoclonal antibodies, which in theory combine high specificity with low immunogenicity, represent a class of potential therapeutic agents. But nearly 20 years after Kohler and Milstein first developed methods for obtaining mouse antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31cf2d12330488ea0a15e5de96ea7854
https://pubmed.ncbi.nlm.nih.gov/8159237
https://pubmed.ncbi.nlm.nih.gov/8159237
Publikováno v:
Laboratory Animals; Jan2004, Vol. 38 Issue 1, p38-43, 6p